Die meistzitierten Artikel
|
Rang |
Autoren |
Paper |
Zitierungen |
1. | Maini R, ..., Kalden J, ..., Smolen J, ..., Lipsky P | Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) ver-sus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. LANCET 354 (9194): 1932-39 DEC 4 1999 | 307 |
2. | Maini RN, ..., Kalden JR, Smolen JS, ..., Feldmann M | Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis. ARTHRITIS AND RHEUM. 41 (9): 1552-63 SEP 1998 | 290 |
3. | Lipsky PE, ..., Kalden JR, Smolen JS, ..., Maini RN | Infliximab and methotrexate in the treatment of rheumatoid arthritis. NEW ENGLAND JOURNAL OF MEDICINE 343 (22): 1594-1602 NOV 30 2000 | 284 |
4. | Bresnihan B, ..., Rau R, ..., Musikic P | Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist. ARTHRITIS AND RHEUMATISM 41 (12): 2196-2204 DEC 1998 | 228 |
5. | Smolen JS, Kalden JR, ..., Loew-Friedrich I, Oed C, Rosenburg R | Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. LANCET 353 (9149): 259-266 JAN 23 1999 | 185 |
6. | Emery P, Zeidler H, ..., Geis GS | Celecoxib vs. diclofenac in long-term management of rheumatoid arthritis: rando-mised double-blind comparison. LANCET 354 (9196): 2106-11 DEC 18 1999 | 154 |
7. | Hagen EC, ..., Andrassy K, Csernok E, ..., van der Woude FJ | Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. KIDNEY INTERNATIONAL 53 (3): 743-753 MAR 1998 | 149 |
8. | Siveke JT, Hamann A | Cutting edge: T helper 1 and T helper 2 cells respond differentially to chemokines. JOURNAL OF IMMUNOLOGY 160 (2): 550-554 JAN 15 1998 | 132 |
9. | Brandt J, Haibel H, Cornely D, Golder W, Gonzalez J, Reddig J, Thriene W, Sieper J, Braun J | Successful treatment of active ankylosing spondylitis with the anti-tumor necrosis factor alpha monoclonal antibody infliximab. ARTHRITIS AND RHEUMATISM 43 (6): 1346-1352 JUN 2000 | 132 |
10. | Ouyang WJ, Lohning M, Gao ZG, | Assenmacher M, Ranganath S, Radbruch A, Murphy KM IMMUNITY 12 (1): 27-37 JAN 2000 | 126 |
|